TrialEuropean journal of nuclear medicine and molecular imaging2016

(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.

Cristina Nanni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.